izumi.yoshida@metagentx.com (Yamagata, Japan, April 7, 2025) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; President & CEO: Taku Nakahara), a company focusing on drug discovery and development of intestinal microbiome-based therapeutics for various diseases, will have its Chief Scientific Officer Jun Terauchi as speaker at the 14th Asia Partnership Conference of Pharmaceutical Associations, to be held in Tokyo, Japan on April 22, 2025.
APAC is an industry-driven initiative with 13 R&D-based pharmaceutical associations joining from 11 regions in Asia working together to realize the mission “To expedite the launch of innovative medicines for the peoples in Asia”. Since its establishment in 2012, APAC has provided unique opportunities for constructive discussions among regulatory authorities, academia and industries on timely topics to improve “Access to Innovative Medicines” (ATIM) in Asia.
■Schedule
11:42～11:50 Accelerating Microbiome-Based Drug Discovery in Asia: The Power of Public-Private Partnerships
Jun Terauchi, Japan Microbiome Consortium / Metagen Therapeutics, Inc.
For more information, please visit the following website:
■『The 14th Asia Partnership Conference of Pharmaceutical Associations (The 14th APAC)』